Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $162,038,028    

Indirect Value

   $374,282,250      
Total Shares   71,480,988      
Total Value   $536,320,277      


Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 8 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-23 4 B $8.00 $1,328,800 I/I 166,100 1,915,947 2.25 -
AQB Aquabounty Technologies, ... 10% Owner   –       –       •   2020-12-17 4 A $0.00 $0 I/I 169,231 11,917 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-10-31 4 A $5.54 $999,513 I/I 170,697 2,897,598 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-22 4 B $4.70 $812,061 I/I 172,779 149,750 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-06 4 B $5.23 $909,717 I/I 173,942 1,113,111 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-28 4 A $5.46 $999,942 I/I 174,954 2,422,517 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-20 4 B $5.85 $1,026,675 I/I 175,500 558,191 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-16 4 B $8.19 $1,437,509 I/I 175,520 1,638,224 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-12-31 4 A $5.66 $1,000,640 I/I 175,879 3,188,586 0 -
CLDA Clinical Data Inc Director   –       •       •   2007-02-26 4 OE $19.45 $3,585,802 I/I 184,360 193,343 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-03 4 A $4.33 $800,569 I/I 184,889 2,276,030 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-11-29 4 A $5.35 $1,000,123 I/I 185,079 3,047,141 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-29 4 B $4.68 $878,338 I/I 187,679 152,045 2.64 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-10 4 S $17.08 $3,466,540 I/I (202,959) 3,276,273 0 -
AQB Aquabounty Technologies, ... 10% Owner   –       –       •   2020-12-17 4 D $0.00 $0 I/I (203,319) 0 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-30 4 B $4.79 $982,237 I/I 205,060 1,051,213 2.64 -
PGEN Precigen Inc Director   –       •       •   2021-11-22 4 B $3.52 $739,979 I/I 206,004 513,665 2.25 %
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-03-18 4 B $4.57 $948,485 I/I 207,546 4,177,546 2.25 -
PGEN Precigen Inc   –       •       •   2024-03-09 4 OE $0.00 $0 I/I 213,675 32,051,461 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-14 4 B $8.13 $1,788,600 I/I 220,000 1,220,000 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-07 4 B $5.26 $1,169,587 I/I 222,355 157,413 2.64 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-09 4 S $17.48 $3,900,260 I/I (223,127) 3,396,879 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2015-12-07 4 B $30.69 $7,289,642 I/I 237,525 6,483,692 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-17 4 B $8.66 $2,061,253 I/I 238,020 3,931,426 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-15 4 B $8.18 $1,985,319 I/I 242,704 1,462,704 2.25 -
  271  Records found
  1   2   3   4   5   6   7   8  9   10   11      
  Page 8 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us